|
1.
|
Xing CG, Zhu BS, Liu HH, Lin F, Yao HH,
Liang ZQ and Qin ZH: LY294002 induces p53-dependent apoptosis of
SGC7901 gastric cancer cells. Acta Pharmacol Sin. 29:489–498. 2008.
View Article : Google Scholar : PubMed/NCBI
|
|
2.
|
Wu CY, Wang CJ, Tseng CC, Chen HP, Wu MS,
Lin JT, Inoue H and Chen GH: Helicobacter pylori promote
gastric cancer cells invasion through a NF-kappaB and
COX-2-mediated pathway. World J Gastroenterol. 11:3197–3203. 2005.
View Article : Google Scholar
|
|
3.
|
Fernandez HA, Kallenbach K, Seghezzi G,
Grossi E, Colvin S, Schneider R, Mignatti P and Galloway A:
Inhibition of endothelial cell migration by gene transfer of tissue
inhibitor of metalloproteinases-1. J Surg Res. 82:156–162. 1999.
View Article : Google Scholar : PubMed/NCBI
|
|
4.
|
Lazăr D, Tăban S, Raica M, Sporea I,
Cornianu M, Goldiş A and Vernic C: Immunohistochemical evaluation
of the tumor neoangiogenesis as a prognostic factor for gastric
cancers. Rom J Morphol Embryol. 49:137–48. 2008.PubMed/NCBI
|
|
5.
|
Wang J, Tian XF, Wang S, Ma LF and Yao JH:
Correlation between expression of matrix metalloproteinase-2,
matrix metal-loproteinase-9 and angiogenesis in gastric cancer.
Chin J Cancer Res. 17:283–287. 2005. View Article : Google Scholar
|
|
6.
|
Sun WH, Sun YL, Fang RN, Shao Y, Xu HC,
Xue QP, Ding GX and Cheng YL: Expression of cyclooxygenase-2 and
matrix metalloproteinase-9 in gastric carcinoma and its correlation
with angiogenesis. Jpn J Clin Oncol. 35:707–713. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
7.
|
Gerber HP and Ferrara N: The role of VEGF
in normal and neoplastic hematopoiesis. J Mol Med (Berl). 81:20–31.
2003.PubMed/NCBI
|
|
8.
|
Vacca A, Ria R, Ribatti D, Semeraro F,
Djonov V, Di Raimondo F and Dammacco F: A paracrine loop in the
vascular endothelial growth factor pathway triggers tumor
angiogenesis and growth in multiple myeloma. Haematologica.
88:176–185. 2003.PubMed/NCBI
|
|
9.
|
Hall PA, Levison DA, Woods AL, et al:
Proliferating cell nuclear antigen (PCNA) immunolocalization in
paraffin sections: an index of cell proliferation with evidence of
deregulated expression in some neoplasms. J Pathol. 162:285–294.
1990. View Article : Google Scholar : PubMed/NCBI
|
|
10.
|
Luque I and Gélinas C: Rel/NF-kappa B and
I kappa B factors in oncogenesis. Semin Cancer Biol. 8:103–111.
1997. View Article : Google Scholar : PubMed/NCBI
|
|
11.
|
Haerslev T and Jacobsen GK: Proliferating
cell nuclear antigen in breast carcinomas. An immunohistochemical
study with correlation to histopathological features and prognostic
factors. Virchows Arch. 424:39–46. 1994.PubMed/NCBI
|
|
12.
|
Jónsson ZO and Hübscher U: Proliferating
cell nuclear antigen: more than a clamp for DNA polymerases.
Bioessays. 19:967–975. 1997.PubMed/NCBI
|
|
13.
|
Baldwin AS: Control of oncogenesis and
cancer therapy resistance by the transcription factor NF-kappaB. J
Clin Invest. 107:241–246. 2001. View
Article : Google Scholar : PubMed/NCBI
|
|
14.
|
Zhu B, Xing C, Lin F, Fan X, Zhao K and
Qin Z: Blocking NF-κB nuclear translocation leads to p53-related
autophagy activation and cell apoptosis. World J Gastroenterol.
17:478–487. 2011.
|
|
15.
|
Zhou HB, Chen JM, Cai JT, Du Q and Wu CN:
Anticancer activity of genistein on implanted tumor of human SG7901
cells in nude mice. World J Gastroenterol. 14:627–631. 2008.
View Article : Google Scholar : PubMed/NCBI
|
|
16.
|
Wang CY, Guttridge DC, Mayo MW and Baldwin
AS Jr: NF-kappaB induces expression of the Bcl-2 homologue A1/Bfl-1
to preferentially suppress chemotherapy-induced apoptosis. Mol Cell
Biol. 19:5923–5929. 1999.PubMed/NCBI
|
|
17.
|
Wang CY, Mayo MW, Korneluk RG, Goeddel DV
and Baldwin AS Jr: NF-kappaB antiapoptosis: induction of TRAF1 and
TRAF2 and c-IAP1 and c-IAP2 to suppress caspase-8 activation.
Science. 281:1680–1683. 1998. View Article : Google Scholar : PubMed/NCBI
|
|
18.
|
Mitsiades N, Mitsiades CS, Poulaki V,
Anderson KC and Treon SP: Intracellular regulation of tumor
necrosis factor-related apoptosis-inducing ligand-induced apoptosis
in human multiple myeloma cells. Blood. 99:2162–2171. 2002.
View Article : Google Scholar
|
|
19.
|
Egeblad M and Werb Z: New functions for
the matrix metal-loproteinases in cancer progression. Nat Rev
Cancer. 2:161–174. 2002. View
Article : Google Scholar : PubMed/NCBI
|
|
20.
|
Kabashima A, Yao T, Sugimachi K and
Tsuneyoshi M: Relationship between biologic behavior and phenotypic
expression in intramucosal gastric carcinomas. Hum Pathol.
33:80–86. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
21.
|
Cai H, Kong ZR and Chen HM: Matrix
metalloproteinase-2 and angiogenesis in gastric cancer. Ai Zheng.
21:25–28. 2002.(In Chinese).
|
|
22.
|
Takahashi Y, Kitadai Y, Ellis LM, Bucana
CD, Fidler IJ and Mai M: Multiparametric in situ mRNA hybridization
analysis of gastric biopsies predicts lymph node metastasis in
patients with gastric carcinoma. Jpn J Cancer Res. 93:1258–1265.
2002. View Article : Google Scholar : PubMed/NCBI
|
|
23.
|
Gomez DE, Alonso DF, Yoshiji H and
Thorgeirsson UP: Tissue inhibitors of metalloproteinases:
structure, regulation and biological functions. Eur J Cell Biol.
74:111–122. 1997.PubMed/NCBI
|
|
24.
|
Brand K: Cancer gene therapy with tissue
inhibitors of metal-loproteinases (TIMPs). Curr Gene Ther.
2:255–271. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
25.
|
Jiang Y, Goldberg ID and Shi YE: Complex
roles of tissue inhibitors of metalloproteinases in cancer.
Oncogene. 21:2245–2252. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
26.
|
Chang C and Werb Z: The many faces of
metalloproteases: cell growth, invasion, angiogenesis and
metastasis. Trends Cell Biol. 11:S37–S43. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
27.
|
Giannelli G and Antonaci S: Gelatinases
and their inhibitors in tumor metastasis: from biological research
to medical applications. Histol Histopathol. 17:339–345.
2002.PubMed/NCBI
|
|
28.
|
Yoon SO, Park SJ, Yun CH and Chung AS:
Roles of matrix metal-loproteinases in tumor metastasis and
angiogenesis. J Biochem Mol Biol. 36:128–137. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
29.
|
Giavazzi R, Sennino B, Coltrini D,
Garofalo A, Dossi R, Ronca R, Tosatti MP and Presta M: Distinct
role of fibroblast growth factor-2 and vascular endothelial growth
factor on tumor growth and angiogenesis. Am J Pathol.
162:1913–1926. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
30.
|
Ferrara N: Role of vascular endothelial
growth factor in physiologic and pathologic angiogenesis:
therapeutic implications. Semin Oncol. 29:10–14. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
31.
|
Bellamy WT: Expression of vascular
endothelial growth factor and its receptors in multiple myeloma and
other hematopoietic malignancies. Semin Oncol. 28:551–559. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
32.
|
Tian X, Song S, Wu J, Meng L, Dong Z and
Shou C: Vascular endothelial growth factor: acting as an autocrine
growth factor for human gastric adenocarcinoma cell MGC803. Biochem
Biophys Res Commun. 286:505–512. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
33.
|
Mao ZB, Xiao MB, Huang JF, Ni HB, Ni RZ,
Wei Q and Zhang H: Expression of VEGF and its signification in
serum of gastric cancer. Shijie Huaren Xiaohua Zazhi. 10:1220–1221.
2002.
|
|
34.
|
Lou G, Gao Y, Ning XM and Zhang QF:
Expression and correlation of CD44v6, vascular endothelial growth
factor, matrix metalloproteinase-2, and matrix metalloproteinase-9
in Krukenberg tumor. World J Gastroenterol. 11:5032–5036. 2005.
|
